Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05498337
Other study ID # Vital pulp therapy
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 1, 2022
Est. completion date March 1, 2024

Study information

Verified date August 2022
Source Mansoura University
Contact Nada M Abdelkader, As. lecturer
Phone +201006429239
Email nadaabdelkader86@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will be conducted to: Evaluate clinically and radiographically apexogenesis in immature permanent molars using: 1. Calcium Hydroxide. 2. MTA. 3. Laser. 4. Laser combined with MTA.


Description:

Calcium Hydroxide has been the most commonly utilized pulpotomy agent for vital pulp therapy. It is the earliest medicament employed in pulpotomy that possesses the ability to stimulate tertiary dentinogenesis. This is attributed to its high alkalinity after mixing with water. Calcium hydroxide has a high pH, and its dental use relates chiefly to its ability to stimulate mineralization and also to its antibacterial property. Biocompatibility and sealing ability are the most important properties, which account for optimal healing response in vital pulp therapy. Unlike conventional materials, MTA has low solubility and maintains its physical integrity after placement. It has several desirable characteristics in terms of biocompatibility, bioactivity, hydrophilicity, radiopacity, sealing ability and low solubility. Diode laser in a young permanent tooth with traumatically exposed pulp has proved to be an effective technique for Pulpotomy in an immature tooth. Therefore, the use of soft-tissue diode lasers can influence the treatment outcome and should be seen as a predicable tool for vital pulp therapy.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date March 1, 2024
Est. primary completion date September 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 7 Years to 9 Years
Eligibility Inclusion Criteria: - Medically free - Vital teeth Exclusion Criteria: - Medically compromised - Chronic abscess - Non-vital teeth

Study Design


Related Conditions & MeSH terms


Intervention

Other:
calcium hydroxide
Dental pulp medicament material
MTA
Dental pulp medicament material
Device:
Diode Laser
Device used in pulp therapy

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University

Outcome

Type Measure Description Time frame Safety issue
Other Clinical evaluation Absence of pain and tenderness to percussion using facial scale one year
Primary Root completion Closure of radiographic apex using Scanora 5.2.6 digital software one year
Secondary Root lengthening and thickening Measuring the increase in length and width of the root canals using Scanora 5.2.6 digital software one year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06348914 - Knowledge of Vital Pulp Therapy in Permanent Teeth Among a Group of Dental Students in Egypt
Completed NCT05167123 - Pulp Capping in Primary Molars Using TheraCal (LC) Phase 4
Recruiting NCT06372561 - Comparative Evaluation of Melatonin Versus MTA on Vital Pulp Therapy in Young Permanent First Molars: An in Vivo Study N/A
Completed NCT02574468 - Effect of Topical Dexamethasone on Histologic Response of Human Dental Pulp Phase 4
Completed NCT05464797 - Diagnostic Biomarkers to Correlate Molecular Changes and Inflammatory Cascade in the Dental Pulp. N/A
Not yet recruiting NCT06111703 - Knowledge, Attitude and Practice in Utilization of Vital Pulp Therapy in Permanent Teeth by Pediatric Dentists in Egypt
Completed NCT05970536 - Vital Pulp Therapy of Mature Permanent Teeth With Irreversible Pulpitis Using Bioceramic Material N/A
Not yet recruiting NCT06232941 - Comparative Evaluation of Three Pulpotomy Agents for Permanent Mature Molars With Irreversible Pulpitis N/A